Latest Rhythm News & Updates

See the latest news and media coverage for Rhythm. We track all announcements, press releases, and industry mentions in real time, all in one place.

Company icon
Rhythm

100% renewable electricity provider in Texas

gotrhythm.com
Headquarters
Houston, United States
Founded year
2020
Company type
Private company
Number of employees
90–200

Last updated

Latest news about Rhythm

In short: Rhythm Energy acquired Inspire Clean Energy and was named Retail Energy Supplier of the Year while expanded its renewable service offerings.

Company announcements

  • Rhythm

    Rhythm wins Retail Energy Supplier of the Year at EMC25

    This marks their second win. The award reflects national expansion and scaling of innovative renewable energy solutions.

  • Rhythm

    Rhythm launches battery-focused VPP initiative

    It partners with Origin Energy’s Kinergy and Intertrust to enhance interoperability and scalability in Texas. Matthew Tolliver emphasizes aligning market expertise with customer experience.

  • Rhythm

    Rhythm Energy expands PowerShift plans to small businesses

    Introduces All Business and PowerShift Business, 100% renewable plans with flexible pricing for cost savings. Available in 12-, 24-, and 36-month terms.

  • Rhythm

    Rhythm partners with Kinergy and Intertrust for VPP

    The partnership delivers secure, standards-based connectivity for distributed energy resources in Texas, scaling to hundreds of battery systems. It uses TEIA standards to avoid vendor lock-in.

Unlock all announcements with a

Media coverage

  • Yahoo Finance

    Rhythm Energy Named Retail Energy Supplier of the Year at EMC25

    Rhythm Energy was named Retail Energy Supplier of the Year for demonstrating leadership in customer experience and innovation, and industry impact.

  • Yahoo Finance

    SIGA Technologies, Inc. Q1 2026 Earnings Call Summary

    Q1 2026 Earnings Call Summary - Moby Strategic Positioning and Operational Context Performance is...

  • Yahoo Finance

    Rhythm Pharmaceuticals Weighs Long Term IMCIVREE Data And Growth Potential

    Rhythm Pharmaceuticals (NasdaqGM:RYTM) presented new long term efficacy and safety data for...

  • Yahoo Finance

    Rhythm Pharmaceuticals Announces IMCIVREE® (Setmelanotide) Granted Marketing Authorization by European Commission for the Treatment of Obesity and Control of Hunger in ...

    First therapy to be FDA-approved and EC-authorized for acquired hypothalamic obesity -- -- European Commission grants authorization in adults and children 4 years of age...

Unlock all articles with a

Never miss news about Rhythm

Track Rhythm and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.